Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-6 and TNF-alpha polymorphisms and flu-like syndrome during intramuscular interferon beta-1a treatment in relapsing-remitting multiple sclerosis
2009-017003-28Phase 4Completed
- Sponsor
- Biogen Dompé
- Start
- Apr 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of interferon beta-1a in multiple sclerosis (MS), sponsored by Biogen Dompé. Started Apr 2010; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-017003-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017003-28.